VivoSim Labs, Inc. Inventory Write-down
VivoSim Labs, Inc. (VIVS) reported Inventory Write-down of $0 for the 12-month period ending 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-07-14
- VivoSim Labs, Inc. inventory write-down for the quarter ending 2026-03-31 was $0.00.
- VivoSim Labs, Inc. inventory write-down for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. inventory write-down for the quarter ending 2025-03-31 was $0.00.
- VivoSim Labs, Inc. inventory write-down for the quarter ending 2024-12-31 was $600.00K.
- VivoSim Labs, Inc. inventory write-down for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- VivoSim Labs, Inc. inventory write-down for fiscal 2025 was $798.00K.
- VivoSim Labs, Inc. inventory write-down for fiscal 2024 was $0.00.
- VivoSim Labs, Inc. inventory write-down for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $0.00 derived: sum of 2 quarters · filed 2026-07-14 | $0.00 10-K · filed 2026-07-14 | |
| 2025-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | $0.00 10-Q · filed 2026-02-11 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | |||
| 2025-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $600.00K derived: sum of 2 quarters · filed 2026-07-14 | $798.00K 10-K · filed 2026-07-14 | |
| 2024-12-31 | $600.00K 10-Q · filed 2025-02-19 | $798.00K 10-Q · filed 2026-02-11 | ||
| 2024-09-30 | $160.00K 10-Q · filed 2025-11-06 | |||
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-05 | $0.00 10-K · filed 2025-06-05 | ||
| 2023-12-31 | $0.00 10-Q · filed 2025-02-19 | |||
| 2021-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $0.00 derived: sum of 2 quarters · filed 2021-06-15 | $0.00 10-K · filed 2021-06-15 | |
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-08 | $0.00 10-Q · filed 2021-02-08 | ||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | |||
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $0.00 derived: sum of 2 quarters · filed 2021-06-15 | $200.00K derived: sum of 3 quarters · filed 2021-06-15 | $214.00K 10-K · filed 2021-06-15 |
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-08 | $200.00K derived: sum of 2 quarters · filed 2021-02-08 | $214.00K 10-Q · filed 2021-02-08 | |
| 2019-09-30 | $200.00K 10-K · filed 2020-05-28 | $214.00K 10-Q · filed 2020-11-05 | ||
| 2019-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | $0.00 derived: sum of 2 quarters · filed 2020-05-28 | $0.00 10-K · filed 2020-05-28 | |
| 2018-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $0.00 10-Q · filed 2020-02-10 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |